Article

Inhibition of adipose tissue-derived fatty acid binding protein suppresses pancreatic cancer progression and metastasis

2024-12-10

Abstract excerpt

<title>Abstract</title> <p>Background Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers, and obesity is a known risk factor for PDAC. Fatty acid binding protein 4 (FABP4) is noted to be higher in obese patients, and linked to the progression of obesity-related cancers. This study aimed to elucidate the role of FABP4 and the anticancer effect of FABP4 inhibition in PDAC using preclinic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5bafe28e-8bfb-573d-b101-ebba14560c55
DOI: 10.21203/rs.3.rs-5404541/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Inhibition of adipose tissue-derived fatty acid binding protein suppresses pancreatic cancer progression and metastasisDOI 10.21203/rs.3.rs-5404541/v1Read

Oxysterol-Binding Protein 2 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Epithelial-Mesenchymal Transition ProcessSemantic proximity Read

Identification of novel candidate biomarkers and efficacious small molecule drugs for pancreatic adenocarcinoma based on comprehensive bioinformatics technologySemantic proximity Read

Diagnostic, Prognostic, and Immunological Roles of FABP4 in Pancancer: A Bioinformatics AnalysisSemantic proximity Read

SREBP1 is associated with lipid-metabolic reprogramming and apoptotic regulation in pancreatic ductal adenocarcinomaSemantic proximity Read

PAFAH1B3 is a KLF9 target gene and promotes proliferation and metastasis in pancreatic cancerSemantic proximity Read

FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expressionSemantic proximity Read

Repurposing DPP-4 inhibitors as anticancer agents in KRAS-mutated pancreatic ductal adenocarcinoma.Semantic proximity Read

PPP3CB inhibits pancreatic cancer progression via promoting translocation of ATOH8 and further transcriptionally regulating Sp1Semantic proximity Read

N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistanceSemantic proximity Read

Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drugSemantic proximity Read

A pancreatic cancer organoid platform identifies an inhibitor specific to mutant KRAS.Semantic proximity Read

Metformin inhibits pancreatic cancer metastasis caused by SMAD4 deficiency and consequent HNF4G upregulationSemantic proximity Read